108 results
Page 4 of 6
424B3
EX-10.1
trtkm83ra837j9iq0 8v
12 Nov 21
Prospectus supplement
8:41am
424B3
m4m0vx
28 Sep 21
Prospectus supplement
9:07am
8-K
EX-99.1
cgesh
28 Sep 21
Entry into a Material Definitive Agreement
8:53am
8-K
EX-99.1
4lf tagn9csop
13 Aug 21
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
7:00am
424B3
svmkqcd7
5 Aug 21
Prospectus supplement
4:26pm
8-K
EX-10.6
z7p nqb2wh
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.4
0sy5o1ew38a0sy
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.5
3c9pikpv
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.2
2k8ae3 dd7upg
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.8
2vo1 evl7s
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.7
o1ozm6syj7f3p7 1g04
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
424B3
a3w o68h1138
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.13
r5jywnq
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.19
biow 88uprl6hpvywz1
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
f4i634gywnef vepa
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.16
6i6w3vntps2so64q
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm